Science Explorer Back to mapMap
Discussion
Company · Las Vegas · United States

Samaritan Pharmaceuticals (United States)

samaritanpharma.comROR OpenAlex
Research works
5
fractional, all time
Citations
122
26.3 per fractional work
Top-10% rate
9.1%
all institutions 10.0%
Open access
14%
world 40%
International
21%
world 18%
Samaritan Pharmaceuticals (United States)

Not ranked overall: Samaritan Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Samaritan Pharmaceuticals (United States) work in?

In all years, 54% of research at Samaritan Pharmaceuticals (United States) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (54%), Biochemistry, Genetics and Molecular Biology (28%), Neuroscience (7%). It does 1.4× the world's share of Health Sciences.

Health Sciences: 2 fractional works · 54.3% of its workMedicine: 2 fractional works · 54.3% of its workLife Sciences: 2 fractional works · 37.0% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 28.3% of its workNeuroscience: 0 fractional works · 6.5% of its workImmunology and Microbiology: 0 fractional works · 2.2% of its workPhysical Sciences: 0 fractional works · 8.7% of its workChemistry: 0 fractional works · 4.3% of its workComputer Science: 0 fractional works · 4.3% of its workALL ITS WORKSamaritanPharmaceuticals…5fractional works, all years
Life Sciences37%Physical Sciences9%Health Sciences54%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Medicine254.3%
    1. Biochemistry, Genetics and Molecular Biology128.3%
    2. Neuroscience06.5%
    3. Immunology and Microbiology02.2%
    1. Chemistry04.3%
    2. Computer Science04.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Samaritan Pharmaceuticals (United States)?

The most cited paper from Samaritan Pharmaceuticals (United States) is "Beta-Amyloid and Oxidative Stress Jointly Induce Neuronal Death, Amyloid Deposits, Gliosis, and Memory Impairment in the Rat Brain" (Laurent Lecanu, Janet Greeson, Vassilios D. Papadopoulos, 2005), with 59 citations. Next come "Identification of naturally occurring spirostenols preventing β-amyloid-induced neurotoxicity" (49) and "The spirostenol (22R, 25R)-20α-spirost-5-en-3β-yl hexanoate blocks mitochondrial uptake of Aβ in neuronal cells and prevents Aβ-induced impairment of mitochondrial function" (47).

Most cited papers
#PaperReleasedCitations
1 Beta-Amyloid and Oxidative Stress Jointly Induce Neuronal Death, Amyloid Deposits, Gliosis, and Memory Impairment in the Rat Brain Laurent Lecanu, Janet Greeson, Vassilios D. Papadopoulos · Pharmacology 14 Oct 2005 59
2 Identification of naturally occurring spirostenols preventing β-amyloid-induced neurotoxicity Laurent Lecanu, Wenguo Yao, Gary Teper et al. · Steroids 6 Dec 2003 49
3 The spirostenol (22R, 25R)-20α-spirost-5-en-3β-yl hexanoate blocks mitochondrial uptake of Aβ in neuronal cells and prevents Aβ-induced impairment of mitochondrial function Laurent Tillement, Laurent Lecanu, Wenguo Yao et al. · Steroids 20 Jun 2006 47
4 22R‐Hydroxycholesterol protects neuronal cells from β‐amyloid‐induced cytotoxicity by binding to β‐amyloid peptide Zhixing Yao, Rachel C. Brown, Gary Teper et al. · Journal of Neurochemistry 19 Nov 2002 47
5 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA Nagaraju Akula, Laurent Lecanu, Janet Greeson et al. · Bioorganic & Medicinal Chemistry Letters 18 Oct 2006 42
All 13 most cited papers, with filters and sorting

Which research topics does Samaritan Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Virology and Viral Diseases, Diphtheria, Corynebacterium, and Tetanus and Vaccine Coverage and Hesitancy.

  1. 1 Virology and Viral Diseases Epidemiology 0 works
  2. 2 Diphtheria, Corynebacterium, and Tetanus Endocrinology 0 works
  3. 3 Vaccine Coverage and Hesitancy Health 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available13.9%not open86.1%

World: 40% of research is openly available.

with international co-authors21.1%domestic only78.9%

World: 18% is written across borders.

How has Samaritan Pharmaceuticals (United States)'s research output changed?

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Las Vegas

All research institutions in Las Vegas

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Samaritan Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.